These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18762255)

  • 1. Use of spray-dried chitosan acetate and ethylcellulose as compression coats for colonic drug delivery: effect of swelling on triggering in vitro drug release.
    Nunthanid J; Luangtana-anan M; Sriamornsak P; Limmatvapirat S; Huanbutta K; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2009 Feb; 71(2):356-61. PubMed ID: 18762255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose.
    Nunthanid J; Huanbutta K; Luangtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 Feb; 68(2):253-9. PubMed ID: 17616377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swelling kinetics of spray-dried chitosan acetate assessed by magnetic resonance imaging and their relation to drug release kinetics of chitosan matrix tablets.
    Huanbutta K; Sriamornsak P; Limmatvapirat S; Luangtana-anan M; Yoshihashi Y; Yonemochi E; Terada K; Nunthanid J
    Eur J Pharm Biopharm; 2011 Feb; 77(2):320-6. PubMed ID: 21129484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
    Zambito Y; Di Colo G
    J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
    Nguyen C; Christensen JM; Ayres JW
    Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-specific drug delivery using ethylcellulose and chitosan in the coat of compression-coated tablets.
    Omwancha W; Kouba C; Yelamanchili S; Neau SH
    Drug Dev Ind Pharm; 2011 Aug; 37(8):945-53. PubMed ID: 21417614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
    Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K
    Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective drug delivery to the colon using pectin-coated pellets.
    He W; Qing D; Cao DY; Fan LF; Xiang B
    PDA J Pharm Sci Technol; 2008; 62(4):264-72. PubMed ID: 19174955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
    Newton AM; Lakshmanan P
    Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of chitosan acetate as a binder for sustained release tablets.
    Nunthanid J; Laungtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S; Lim LY; Khor E
    J Control Release; 2004 Sep; 99(1):15-26. PubMed ID: 15342177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in-vitro evaluation of a colon-specific controlled release drug delivery system.
    Talukder RM; Fassihi R
    J Pharm Pharmacol; 2008 Oct; 60(10):1297-303. PubMed ID: 18812022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid.
    Cheng G; An F; Zou MJ; Sun J; Hao XH; He YX
    World J Gastroenterol; 2004 Jun; 10(12):1769-74. PubMed ID: 15188503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro evaluation of pH, time-based and enzyme-degradable pellets for colonic drug delivery.
    Fude C; Lei Y; Jie J; Hongze P; Wenhui L; Dongmei C
    Drug Dev Ind Pharm; 2007 Sep; 33(9):999-1007. PubMed ID: 17891587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.